Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(20)30735-0
PubMed Identifier: 33516293
Publication URI: http://europepmc.org/abstract/MED/33516293
Type: Journal Article/Review
Volume: 21
Parent Publication: The Lancet. Infectious diseases
Issue: 6
ISSN: 1473-3099